A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination

Dermatol Online J. 2022 Aug 15;28(4). doi: 10.5070/D328458525.

Abstract

The rapid development and implementation of COVID-19 vaccines throughout the global population has given rise to unique, rare, adverse skin reactions. This case report describes an elderly man with new-onset bullous pemphigoid following the second dose of the Pfizer-BioNTech (mRNA) COVID-19 vaccine.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • COVID-19 Vaccines* / adverse effects
  • COVID-19*
  • Exanthema*
  • Humans
  • Male
  • Pemphigoid, Bullous* / etiology
  • RNA, Messenger
  • Vaccination / adverse effects

Substances

  • COVID-19 Vaccines
  • RNA, Messenger